ICATIBANT for Immune system disorder: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 847 adverse event reports in the FDA FAERS database where ICATIBANT was used for Immune system disorder.
Most Reported Side Effects for ICATIBANT
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Hereditary angioedema | 2,221 | 41.4% | 45 | 1,154 |
| Drug ineffective | 506 | 9.4% | 13 | 244 |
| Product dose omission issue | 421 | 7.9% | 8 | 238 |
| Weight decreased | 386 | 7.2% | 10 | 211 |
| Weight increased | 367 | 6.8% | 6 | 205 |
| Product use issue | 332 | 6.2% | 3 | 174 |
| Injection site pain | 331 | 6.2% | 2 | 106 |
| Inappropriate schedule of product administration | 305 | 5.7% | 5 | 165 |
| Headache | 294 | 5.5% | 3 | 128 |
| Malaise | 262 | 4.9% | 4 | 117 |
| Covid-19 | 260 | 4.9% | 11 | 142 |
| Stress | 234 | 4.4% | 1 | 108 |
| Off label use | 228 | 4.3% | 8 | 122 |
| Pain | 203 | 3.8% | 4 | 93 |
| Fall | 195 | 3.6% | 8 | 99 |
Other Indications for ICATIBANT
Hereditary angioedema (2,660)
Product used for unknown indication (930)
Complement deficiency disease (338)
Complement factor abnormal (306)
Angioedema (153)
Hereditary angioedema with c1 esterase inhibitor deficiency (132)
Hereditary angioedema with normal c1 esterase inhibitor (63)
Prophylaxis (25)
Immunodeficiency (14)
Off label use (13)
Other Drugs Used for Immune system disorder
LANADELUMAB (1,047)
HUMAN IMMUNOGLOBULIN G (508)
HUMAN C1-ESTERASE INHIBITOR (387)
LANADELUMAB-FLYO (327)
ECALLANTIDE (132)
RITUXIMAB (77)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (51)
LENALIDOMIDE (46)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (35)
RUXOLITINIB (35)